fig1 shows an exemplary breast implant constructed in accordance with the principles of the present invention , wherein the breast implant 1 comprises a breast implant with an inner core 3 and first layer 2 , wherein said first layer limits the boundaries of the implant filling . a series of tubes , conducts or channels 4 are positioned on the first layer &# 39 ; s 2 inner aspect . further , a porous core 3 made of a malleable cohesive material having a degree of stiffness to add body comprises a series of interconnected spaces , such as pores spaces , holes or channels , so as to allow inflation of the implant with filling fluid passing through the porous core by means of said interconnected spaces . the filling fluid comprises a selection of a fluid with none or low degree of toxicity towards the human body , such as silicon or saline water . a biodegradable layer 6 which is the second layer of the implant elutes a chemotherapy drug to serve as a regional therapeutic agent and minimize the possibility of encapsulation , said biodegradable layer 6 surrounds the first layer 2 , and an attached third layer 5 extend from the boundaries of the biodegradable layer 6 . the third layer 5 and biodegradable layer 6 can be integrally made . the third layer may also cover and coat entirely the second layer with the extending mesh for attachment . the first layer 2 is made of a non toxic elastic material . the conduct 4 is placed inside the first layer &# 39 ; s inner surface . the first layer holds the inner contents of the implant which are the porous core 3 with filling fluid . the biodegradable layer 6 and extendable attaching layer 5 are located at the outer surface of the first layer ; these are the second and third layers as described earlier . several ports are connected to the first layer 2 , wherein at least a first port 7 serves as an access point to fill the breast implant with a filling material such as silicon or saline water . a second port or therapeutic port 10 serves as an access point to the therapeutic or brachytherapy fluid agent . fig2 through fig8 b are directed to the brachytherapy system . the brachytherapy system comprises at least one tube 4 having an input port 8 to provide the therapy fluid . as shown in fig2 a the conducts 4 are arranged through the lining of the implant in a pre - determined way in order to cover most of the first layer &# 39 ; s inner surface . furthermore , the system &# 39 ; s tube arrangements can be allocated in such way as to particularly select an area or surface to be treated as shown in fig2 b , allowing for partial as well as complete post - mastectomy breast brachytherapy treatment . fig3 a shows an exemplary breast implant 1 constructed in accordance with the principles of the present invention , wherein the arrangement of tubes 4 is divided in at least eight sections , each section representing a quadrant of the breast implant outer surface . the back part of the breast implant 1 is divided into four quadrants and the front or top part is divided into another four quadrants . other divisions can be made as desired , for example the retroareolar area that may be partially irradiated after nipple sparing mastectomy . each quadrant has an input port 8 connected to a main therapeutic port 10 which provides the main access point for supplying the therapy fluid to be used for brachytherapy at each zone or quadrant . in this example , the physician may choose to administer a higher brachytherapy doses to a particular zone of the patient &# 39 ; s mastectomy bed . fig3 b shows the side view of the present embodiment in accordance with the principles of the present invention . the therapeutic port 10 of the breast implant 1 divided into several sections which are disclosed in more detail in fig4 through fig5 c . fig4 omits all the other elements previously described and presents the back aspect of the inner first layer 2 with the therapeutic port 10 . the therapeutic port 10 extends between the boundaries of the first layer 2 at the back of the implant . fig5 a through 5c show in more detail the therapeutic port 10 comprising an elongated body with several openings or inputs 11 serving as connections for conducts 4 on each quadrant . the therapeutic port 10 is divided by soft rings 12 located inside the cylindrical elongated body . the purpose of the rings 12 is to avoid transfer of fluid between sections . for example , if a therapy fluid is to be applied to the first and third quadrant of the implant , the ring 12 avoids the transfer of fluids between the first section , the third section and any other section in between . the therapeutic port 10 has a first funnel - shape input 14 located at a distal end of the elongated body . fig6 shows the brachytherapy fluid supplier 13 wherein the main purpose is to dispense therapeutic fluid into the therapeutic port 10 . the brachytherapy fluid supplier 13 comprises an elongated cylindrical body 13 b with a diameter smaller than the input port 10 , connected to a supplier main body 13 a . said supplier main body 13 a has a second funnel - shaped structure 131 configured to fit said first funnel - shaped input 14 . once both funnel shaped elements are positioned in place the brachytherapy fluid supplier 13 b is inserted through the input port 10 in the implant . the elongated body 13 b comprises an opening at the distal end 13 c serving as an output for the therapeutic agent traveling through the elongated body 13 b . further , a set of balloons 13 d serving as a sealer surrounds the opening and assist the ring 12 to avoid the transfer of therapeutic fluid between quadrants . fig7 a through 7b disclose in more detail the insertion of the fluid supplier 13 in the therapeutic port 10 . the brachytherapy fluid supplier 13 is intended to provide therapeutic fluid to the breast implant quadrants . therefore , the brachytherapy fluid supplier 13 is inserted through the input port 10 until reaching a predetermined section . several procedures may be used to supply the therapy fluid to a particular section . in the present case , the length of the input port is taken into consideration , wherein the brachytherapy fluid supplier 13 is marked to provide visual information of how deep it has been introduced into the input port . the traveled distance of the brachytherapy fluid supplier 13 inside the input port represents the section being reached . fig7 a is directed to the insertion process of the brachytherapy fluid supplier 13 , which is done perpendicularly ( 90 degrees ) to the input port &# 39 ; s surface . as described earlier , both funnel shaped structures , one in the supplier inserter 13 a and the other in the input port 10 in the implant , are positioned using ultrasonic guidance and then the brachytherapy dispenser is introduced . fig8 a through 8b represent the expansion of the conducts 4 after the therapy fluid is supplied . the conducts 4 are configured to expand towards the inner surface of the breast implant . this configuration avoids perceiving deformation at the outer surface of the implant , and consequently breast deformation , maintaining a natural appearance . further , the conduct 4 can be arranged to expand in such way that the whole area is covered by the therapy fluid . after the therapy is performed the therapeutic fluid is removed by a flushing process in order to eliminate the radioactive substance inside the implant 1 . fig9 discloses the biodegradable layer 6 covering the breast implant 1 . the biodegradable layer 6 controls the foreign body &# 39 ; s reaction and therefore minimizes the possibility encapsulation in order to keep a natural feel and appearance . the biodegradable layer covers the first layer of the implant . it can be integrally made with the first layer 2 or added to the surface in the form of mesh or coating . furthermore , the mesh or coating is provided with drug eluting properties for further treatment to the patient . fig1 shows the extendable attaching means for the breast implant 1 , the third layer of the implant . the attaching means 5 are fixed to the breast implant and may be made of a biodegradable material . the attaching means 5 assists with the fixation and / or fastening of the breast implant 1 and serve as a mesh extension around the implant &# 39 ; s border . the third attaching layer can also cover the entire second layer , in this way it will take some time until the body begins the biodegradation process of the drug eluting second layer . this will allow for the wound to heal properly before any chemotherapeutic agent that may affect wound healing is present locally . for example , fig1 shows the breast implant in the patient &# 39 ; s body . the attaching means 5 assists with the fixation and / or fastening process of the breast implant while the conducts 4 are arranged throughout the first layer 2 in order to provide brachytherapy around the implant 1 . furthermore , the breast implant 1 is provided with several ports 8 , 7 , 10 . some ports are directed to the brachytherapy and others are directed to the inflation process of the breast implant 1 . in one embodiment , ultrasound guidance is used to perform this procedure . other guidance methods or procedures may be used alternatively . first , the port for inflation is located substantially at the back part of the breast implant 1 . the location of the port 7 avoids the unpleasant feeling of the port at the outer surface of the patient &# 39 ; s skin , and the use of ultrasound guidance results in the use of a smaller port . in the instant case , the material used for the port is easy to recognize by the ultrasound system . the location of the port , which is assisted by fixing the breast implant in the proper position using the attaching means 5 , is revealed to the physician using the ultrasound system during the inflation process when the patient turns to the side or lateral decubitus position . fig1 shows the process where , after fixing the breast implant 1 , the patient is turned to the side in a lateral decubitus position and the breast displacement will result in revealing the port 7 , 10 . although certain exemplary embodiments and methods have been described in some detail , for clarity of understanding and by way of example , it will be apparent from the foregoing disclosure to those skilled in the art that variations , modifications , changes , and adaptations of such embodiments and methods may be made without departing from the true spirit and scope of the invention . for example , it will be appreciated that one of ordinary skill in the art will be able to employ a number corresponding alternative and equivalent structural details , such as equivalent ways of fastening , mounting , coupling , or engaging tool components , equivalent mechanisms for producing particular actuation motions , and equivalent mechanisms for therapeutic breast implants . therefore , the above description should not be taken as limiting the scope of the invention which is defined by the appended claims .
a breast implant and process to optimize the treatment of breast cancer patients that offers more effective alternatives in breast reconstruction and simultaneously administers regional therapies in order to minimize the possibility of local recurrences . the breast implant comprises an inner porous core contained by an elastic holding layer with a system of tubes and conducts within it covered with biodegradable chemotherapeutic and attaching layers .